Position in FATE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$974,302
+$256,287 QoQ
Shares Held
811,920
+10.8% QoQ
Ownership
0.697%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.04685190659178.ToString("F0")%
Shared 1.9531480934082177.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. FATE ranks #232 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in FATE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $974,302 | 811,920 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $718,015 | 732,670 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,026,224 | 814,465 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $945,670 | 844,350 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $628,027 | 794,973 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,329,102 | 805,518 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,853,058 | 815,160 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $2,416,289 | 736,674 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $5,255,820 | 716,052 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,650,121 | 708,589 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,646,208 | 1,248,212 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,961,713 | 1,252,461 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,476,151 | 785,290 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,703,068 | 763,436 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,204,155 | 767,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,226,973 | 775,907 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $30,234,085 | 779,832 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $47,516,378 | 812,107 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $48,802,738 | 823,397 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $76,781,374 | 884,680 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $72,730,957 | 882,122 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $81,233,949 | 893,368 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $36,676,710 | 917,606 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $30,148,023 | 878,695 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $17,761,779 | 799,720 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||